Molecular and cellular key players in human islet transplantation

Journal of Cellular and Molecular Medicine

Volumn 11, Issue 3, 2007, Pages 398-415

  Hermann, M ^a,b   Margreiter, R ^a   Hengster, P ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b KMT Laboratory   (Austria)

Author keywords

Cell therapy; Diabetes type 1; Islet of Langerhans; Islet transplantations; Real time confocal imaging; Vascularization

Indexed keywords

ANGIOGENESIS; ARTICLE; BIOLOGICAL THERAPY; CYTOLOGY; HUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; STEM CELL; VASCULARIZATION;

HUMANS; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELLS; TISSUE THERAPY;

EID: 34547305785     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2007.00055.x     Document Type: Article

References (96)

1. Humes HD. Cell therapy: leveraging nature's therapeutic potential. J Am Soc Nephrol. 2003 14 : 2211 3.
2. Dove A. Cell-based therapies go live. Nat Biotechnol. 2002 20 : 339 43.
3. Brower V. Human ES cells: Can you build a business around them? Nat Biotechnol. 1999 17 : 139 42.
4. Terada N, Hamazaki T, Oka M, Hoki M, Mastalerz DM, Nakano Y, Meyer EM, Morel L, Petersen BE, Scott EW. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature. 2002 416 : 542 5.
5. Vassilopoulos G, Russell DW. Cell fusion: An alternative to stem cell plasticity and its therapeutic implications. Curr Opin Genet Dev. 2003 13 : 480 5.
6. Wang X, Willenbring H, Akkari Y, Torimaru Y, Foster M, Al-Dhalimy M, Lagasse E, Finegold M, Olson S, Grompe M. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature. 2003 422 : 897 901.
7. Hacein-Bey-Abina S, Von KC, Schmidt M, Le DF, Wulffraat N, McIntyre E, Radford I, Villeval JL, Fraser CC, Cavazzana-Calvo M, Fischer A. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med. 2003 348 : 255 6.
8. Orive G, Hernandez RM, Gascon AR, Calafiore R, Chang TM, De VP, Hortelano G, Hunkeler D, Lacik I, Shapiro AM, Pedraz JL. Cell encapsulation: promise and progress. Nat Med. 2003 9 : 104 7.
9. Atkinson MA, Eisenbarth GS. Type 1 diabetes: New perspectives on disease pathogenesis and treatment. Lancet. 2001 358 : 221 9.
10. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998 21 : 1414 31.
11. Ritz E, Schomig M. The diabetic patient with renal failure. Nefrologia. 2000 20 : 16 24.
12. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001 414 : 813 20.
13. Diamond J. The double puzzle of diabetes. Nature. 2003 423 : 599 602.
14. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001 414 : 782 7.
15. Gautier JF, Beressi JP, Leblanc H, Vexiau P, Passa P. Are the implications of the Diabetes Control And Complications Trial (DCCT) feasible in daily clinical practice? Diabetes Metab. 1996 22 : 415 9.
16. Meivar-Levy I and Ferber S. New organs from our own tissues: liver-to-pancreas transdifferentiation. Trends Endocrinol Metab. 2003 14 : 460 6.
17. Hirshberg B, Rother KI, Gon III BJ, Venstrom J, Harlan DM. State of the art: Islet transplantation for the cure of type 1 diabetes mellitus. Rev Endocr Metab Disord. 2003 4 : 381 9.
18. Robertson RP, Davis C, Larsen J, Stratta R, Sutherland DE. Pancreas and islet transplantation for patients with diabetes. Diabetes Care. 2000 23 : 112 6.
19. Ballinger WF, Lacy PE. Transplantation of intact pancreatic islets in rats. Surgery. 1972 72 : 175 86.
20. Kemp CB, Knight MJ, Scharp DW, Lacy PE, Ballinger WF. Transplantation of isolated pancreatic islets into the portal vein of diabetic rats. Nature. 1973 244 : 447
21. Kandeel F, Smith CV, Todorov I, Mullen Y. Advances in islet cell biology: From stem cell differentiation to clinical transplantation: Conference report. Pancreas. 2003 27 : e63-78.
22. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000 343 : 230 8.
23. Merani S, Shapiro AM. Current status of pancreatic islet transplantation. Clin Sci. 2006 110 : 611 25.
24. Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, Lakey JR, Shapiro AM. Five-year follow-up after clinical islet transplantation. Diabetes. 2005 54 : 2060 9.
25. Brock P, Sparmann G, Ritter T, Jaster R, Liebe S, Emmrich J. Adenovirus-mediated gene transfer of interleukin-4 into pancreatic stellate cells promotes interleukin-10 expression. J Cell Mol Med. 2006 10 : 884 95.
26. Kountouras J, Zavos C, Chatzopoulos D. A concept on the role of Helicobacter pylori infection in autoimmune pancreatitis. J Cell Mol Med. 2005 9 : 196 207.
27. Bhatia M. Molecular mimicry in autoimmune pancreatitis: an interesting idea. J Cell Mol Med. 2005 9 : 745
28. Guarneri F, Guarneri C, Benvenga S. Helicobacter pylori and autoimmune pancreatitis: role of carbonic anhydrase via molecular mimicry? J Cell Mol Med. 2005 9 : 741 4.
29. Robertson RP, Lanz KJ, Sutherland DE, Kendall DM. Prevention of diabetes for up to 13 years by autoislet transplantation after pancreatectomy for chronic pancreatitis. Diabetes. 2001 50 : 47 50.
30. O'Gorman D, Kin T, Murdoch T, Richer B, Ghee-Wilson D, Ryan EA, Shapiro JA, Lakey JR. The standardization of pancreatic donors for islet isolations. Transplantation. 2005 80 : 801 6.
31. Barnett MJ, Ghee-Wilson D, Shapiro AM, Lakey JR. Variation in human islet viability based on different membrane integrity stains. Cell Transplant. 2004 13 : 481 8.
32. Hermann M, Pirkebner D, Draxl A, Margreiter R, Hengster P Real-time" assessment of human islet preparations with confocal live cell imaging. Transplant Proc. 2005 37 : 3409 11.
33. Dor Y, Brown J, Martinez OI, Melton DA. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature. 2004 429 : 41 6.
34. Halvorsen TL, Beattie GM, Lopez AD, Hayek A, Levine F. Accelerated telomere shortening and senescence in human pancreatic islet cells stimulated to divide in vitro. J Endocrinol. 2000 166 : 103 9.
35. Colman A. Making new beta cells from stem cells. Semin Cell Dev Biol. 2004 15 : 337 45.
36. Zhang YQ, Kritzik M, Sarvetnick N. Identification and expansion of pancreatic stem/progenitor cells. J Cell Mol Med. 2005 9 : 331 44.
37. Gershengorn MC, Hardikar AA, Wei C, Geras-Raaka E, Marcus-Samuels B, Raaka BM. Epithelialto-mesenchymal transition generates proliferative human islet precursor cells. Science. 2004 306 : 2261 4.
38. Zalzman M, Nker-Kitai L, Efrat S. Differentiation of human liver-derived, insulin-producing cells toward the beta-cell phenotype. Diabetes. 2005 54 : 2568 75.
39. Narang AS, Mahato RI. Biological and biomaterial approaches for improved islet transplantation. Pharmacol Rev. 2006 58 : 194 243.
40. Narushima M, Kobayashi N, Okitsu T, Tanaka Y, Li SA, Chen Y, Miki A, Tanaka K, Nakaji S, Takei K, Gutierrez AS, Rivas-Carrillo JD, Navarro-Alvarez N, Jun HS, Westerman KA, Noguchi H, Lakey JR, Leboulch P, Tanaka N, Yoon JW. A human beta-cell line for transplantation therapy to control type 1 diabetes. Nat Biotechnol. 2005 23 : 1274 82.
41. Hohmeier HE, Newgard CB. Islets for all? Nat Biotechnol. 2005 23 : 1231 2.
42. Georgia S, Bhushan A. Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. J Clin Invest. 2004 114 : 963 8.
43. Soria B. In-vitro differentiation of pancreatic betacells. Differentiation. 2001 68 : 205 19.
44. Beattie GM, Montgomery AM, Lopez AD, Hao E, Perez B, Just ML, Lakey JR, Hart ME, Hayek A. A novel approach to increase human islet cell mass while preserving beta-cell function. Diabetes. 2002 51 : 3435 9.
45. Beattie GM, Rubin JS, Mally MI, Otonkoski T, Hayek A. Regulation of proliferation and differentiation of human fetal pancreatic islet cells by extracellular matrix, hepatocyte growth factor, and cell-cell contact. Diabetes. 1996 45 : 1223 8.
46. Schroeder IS, Rolletschek A, Blyszczuk P, Kania G, Wobus AM. Differentiation of mouse embryonic stem cells to insulin-producing cells. Nat Protoc. 2006 1 : 495 507.
47. Vasavada RC, Gonzalez-Pertusa JA, Fujinaka Y, Fiaschi-Taesch N, Cozar-Castellano I, Garcia-Ocana A. Growth factors and beta cell replication. Int J Biochem Cell Biol. 2006 38 : 931 50.
48. Sorenson RL, Brelje TC. Adaptation of islets of Langerhans to pregnancy: Beta-cell growth, enhanced insulin secretion and the role of lactogenic hormones. Horm Metab Res. 1997 29 : 301 7.
49. Bonner-Weir S. Islet growth and development in the adult. J Mol Endocrinol. 2000 24 : 297 302.
50. Kloppel G, Lohr M, Habich K, Oberholzer M, Heitz PU. Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res. 1985 4 : 110 25.
51. Bonner-Weir S. Life and death of the pancreatic beta cells. Trends Endocrinol Metab. 2000 11 : 375 8.
52. Sherr CJ. D-type cyclins. Trends Biochem Sci. 1995 20 : 187 90.
53. Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ, Kato JY. D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol. 1994 14 : 2066 76.
54. Ciemerych MA, Kenney AM, Sicinska E, Kalaszczynska I, Bronson RT, Rowitch DH, Gardner H, Sicinski P. Development of mice expressing a single D-type cyclin. Genes Dev. 2002 16 : 3277 89.
55. Laybutt DR, Weir GC, Kaneto H, Lebet J, Palmiter RD, Sharma A, Bonner-Weir S. Overexpression of c-Myc in beta-cells of transgenic mice causes proliferation and apoptosis, downregulation of insulin gene expression, and diabetes. Diabetes. 2002 51 : 1793 804.
56. Kushner JA, Ciemerych MA, Sicinska E, Wartschow LM, Teta M, Long SY, Sicinski P, White MF. Cyclins D2 and D1 are essential for postnatal pancreatic beta-cell growth. Mol Cell Biol. 2005 25 : 3752 62.
57. Kim MJ, Kang JH, Park YG, Ryu GR, Ko SH, Jeong IK, Koh KH, Rhie DJ, Yoon SH, Hahn SJ, Kim MS, Jo YH. Exendin-4 induction of cyclin D1 expression in INS-1 beta-cells: Involvement of cAMP-responsive element. J Endocrinol. 2006 188 : 623 33.
58. Costes S, Broca C, Bertrand G, Lajoix AD, Bataille D, Bockaert J, Dalle S. ERK1/2 control phosphorylation and protein level of cAMP-responsive elementbinding protein: A key role in glucose-mediated pancreatic beta-cell survival. Diabetes. 2006 55 : 2220 30.
59. Yeung K, Seitz T, Li S, Janosch P, McFerran B, Kaiser C, Fee F, Katsanakis KD, Rose DW, Mischak H, Sedivy JM, Kolch W. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature. 1999 401 : 173 7.
60. Zhang L, Fu Z, Binkley C, Giordano T, Burant CF, Logsdon CD, Simeone DM. Raf kinase inhibitory protein inhibits beta-cell proliferation. Surgery. 2004 136 : 708 15.
61. Friedrichsen BN, Richter HE, Hansen JA, Rhodes CJ, Nielsen JH, Billestrup N, Moldrup A. Signal transducer and activator of transcription 5 activation is sufficient to drive transcriptional induction of cyclin D2 gene and proliferation of rat pancreatic beta-cells. Mol Endocrinol. 2003 17 : 945 58.
62. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell. 1995 81 : 323 30.
63. Rane SG, Dubus P, Mettus RV, Galbreath EJ, Boden G, Reddy EP, Barbacid M. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia. Nat Genet. 1999 22 : 44 52.
64. Dunlop M, Muggli E, Clark S. Association of cyclindependent kinase-4 and cyclin D1 in neonatal beta cells after mitogenic stimulation by lysophosphatidic acid. Biochem Biophys Res Commun. 1996 218 : 132 6.
65. Georgia S, Bhushan A. p27 Regulates the transition of beta-cells from quiescence to proliferation. Diabetes. 2006 55 : 2950 6.
66. Gu G, Brown JR, Melton DA. Direct lineage tracing reveals the ontogeny of pancreatic cell fates during mouse embryogenesis. Mech Dev. 2003 120 : 35 43.
67. Lee JC, Smith SB, Watada H, Lin J, Scheel D, Wang J, Mirmira RG, German MS. Regulation of the pancreatic pro-endocrine gene neurogenin3. Diabetes. 2001 50 : 928 36.
68. Georgia S, Soliz R, Li M, Zhang P, Bhushan A. p57 and Hes1 coordinate cell cycle exit with self-renewal of pancreatic progenitors. Dev Biol. 2006 298 : 22 31.
69. Apelqvist A, Li H, Sommer L, Beatus P, Anderson DJ, Honjo T, Hrabe de AM, Lendahl U, Edlund H. Notch signalling controls pancreatic cell differentiation. Nature. 1999 400 : 877 81.
70. Jensen J, Pedersen EE, Galante P, Hald J, Heller RS, Ishibashi M, Kageyama R, Guillemot F, Serup P, Madsen OD. Control of endodermal endocrine development by Hes-1. Nat Genet. 2000 24 : 36 44.
71. Gupta V, Wahoff DC, Rooney DP, Poitout V, Sutherland DE, Kendall DM, Robertson RP. The defective glucagon response from transplanted intrahepatic pancreatic islets during hypoglycaemia is transplantation site-determined. Diabetes. 1997 46 : 28 33.
72. Paty BW, Ryan EA, Shapiro AM, Lakey JR, Robertson RP. Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycaemic hormonal counterregulation or symptom recognition after insulin independence. Diabetes. 2002 51 : 3428 34.
73. Santana A, Ensenat-Waser R, Arribas MI, Reig JA, Roche E. Insulin-producing cells derived from stem cells: Recent progress and future directions. J Cell Mol Med. 2006 10 : 866 83.
74. Ferber S, Heimberg H, Brownlee M, Colton C. Surrogate beta cells. Diabetologia. 1997 40 (Suppl 3 B39 B43
75. Carlsson PO, Palm F, Mattsson G. Low revascularization of experimentally transplanted human pancreatic islets. J Clin Endocrinol Metab. 2002 87 : 5418 23.
76. Bonner-Weir S. Morphological evidence for pancreatic polarity of beta-cell within islets of Langerhans. Diabetes. 1988 37 : 616 21.
77. Hirshberg B, Mog S, Patterson N, Leconte J, Harlan DM. Histopathological study of intrahepatic islets transplanted in the nonhuman primate model using edmonton protocol immunosuppression. J Clin Endocrinol Metab. 2002 87 : 5424 9.
78. Mattsson G, Jansson L, Carlsson PO. Decreased vascular density in mouse pancreatic islets after transplantation. Diabetes. 2002 51 : 1362 6.
79. Carlsson PO, Palm F, Mattsson G. Low revascularization of experimentally transplanted human pancreatic islets. J Clin Endocrinol Metab. 2002 87 : 5418 23.
80. Lammert E, Cleaver O, Melton D. Role of endothelial cells in early pancreas and liver development. Mech Dev. 2003 120 : 59 64.
81. Lammert E, Cleaver O, Melton D. Induction of pancreatic differentiation by signals from blood vessels. Science. 2001 294 : 564 7.
82. Lammert E, Gu G, McLaughlin M, Brown D, Brekken R, Murtaugh LC, Gerber HP, Ferrara N, Melton DA. Role of VEGF-A in vascularization of pancreatic islets. Curr Biol. 2003 13 : 1070 4.
83. Nikolova G, Jabs N, Konstantinova I, Domogatskaya A, Tryggvason K, Sorokin L, Fassler R, Gu G, Gerber HP, Ferrara N, Melton DA, Lammert E. The vascular basement membrane: A niche for insulin gene expression and Beta cell proliferation. Dev Cell. 2006 10 : 397 405.
84. Henderson JR, Moss MC. A morphometric study of the endocrine and exocrine capillaries of the pancreas. Q J Exp Physiol. 1985 70 : 347 56.
85. Konstantinova I, Lammert E. Microvascular development: Learning from pancreatic islets. Bioessays. 2004 26 : 1069 75.
86. Lukinius A, Jansson L, Korsgren O. Ultrastructural evidence for blood microvessels devoid of an endothelial cell lining in transplanted pancreatic islets. Am J Pathol. 1995 146 : 429 35.
87. Jansson L, Carlsson PO. Graft vascular function after transplantation of pancreatic islets. Diabetologia. 2002 45 : 749 63.
88. Zhang N, Richter A, Suriawinata J, Harbaran S, Altomonte J, Cong L, Zhang H, Song K, Meseck M, Bromberg J, Dong H. Elevated vascular endothelial growth factor production in islets improves islet graft vascularization. Diabetes. 2004 53 : 963 70.
89. Hermann M, Pirkebner D, Draxl A, Margreiter R, Hengster P. In the search of potential human islet stem cells: Is tetranectin showing us the way? Transplant Proc. 2005 37 : 1322 5.
90. Christensen L, Johansen N, Jensen BA, Clemmensen I. Immunohistochemical localization of a novel, human plasma protein, tetranectin, in human endocrine tissues. Histochemistry. 1987 87 : 195 9.
91. Wewer UM, Iba K, Durkin ME, Nielsen FC, Loechel F, Gilpin BJ, Kuang W, Engvall E, Albrechtsen R. Tetranectin is a novel marker for myogenesis during embryonic development, muscle regeneration, and muscle cell differentiation in vitro. Dev Biol. 1998 200 : 247 59.
92. Westergaard UB, Andersen MH, Heegaard CW, Fedosov SN, Petersen TE. Tetranectin binds hepatocyte growth factor and tissue-type plasminogen activator. Eur J Biochem. 2003 270 : 1850 4.
93. Westergaard UB, Andersen MH, Heegaard CW, Fedosov SN, Petersen TE. Tetranectin binds hepatocyte growth factor and tissue-type plasminogen activator. Eur J Biochem. 2003 270 : 1850 4.
94. Byun T, Karimi M, Marsh JL, Milovanovic T, Lin F, Holcombe RF. Expression of secreted Wnt antagonists in gastrointestinal tissues: potential role in stem cell homeostasis. J Clin Pathol. 2005 58 : 515 9.
95. Hermann M, Pirkebner D, Draxl A, Berger P, Untergasser G, Margreiter R, Hengster P. Dickkopf-3 is expressed in a subset of adult human pancreatic beta cells. Histochem Cell Biol. 2007 127 : 513 21.
96. Dor Y, Brown J, Martinez OI, Melton DA. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature. 2004 429 : 41 6.